RE:RE:PMN Announces Strategic Priorities for 2021Just man up guys and say we can't make a deal. Hinging PMN 310, Promis's lead candidate for how many years on Biogen's fate or any other Pharma's just confirms this. Everyone knows Biogens products can go a number of different ways. As soon as the funding window re-opens, 10-20 million for a phase 1 pilot with potential biomarker evaluation and can't make a deal? Please don't drum up anymore excuses for one of the worlds most unmet medical needs. With the amyloid theory very much stil in play with big pharma and there billions, either Promis does not have the science they think, or the leadership is incredibily incompetent.